Loading…

Polycyclic aromatic hydrocarbons in a polyherbal drug: human health exposure-associated risk assessment study

PAHs are pervasive pollutants known to bioaccumulate in environmental matrices, plants, and humans. Dr. Iguedo Goko Cleanser® is a polyherbal drug with unsubstantiated claims to treat various diseases in sub-Saharan Africa. PAHs were measured following EPA-16 PAHs guidelines using Gas Chromatography...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental health research 2024-05, p.1-10
Main Authors: Udom, Godswill J, Obilor, Oluchi F, Aziakpono, Omoirri M, Aturamu, Ayodeji, Ogbonnaya, Mba, Umana, Israel K, Udom, Nita-Wills G, Yemitan, Omoniyi K
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PAHs are pervasive pollutants known to bioaccumulate in environmental matrices, plants, and humans. Dr. Iguedo Goko Cleanser® is a polyherbal drug with unsubstantiated claims to treat various diseases in sub-Saharan Africa. PAHs were measured following EPA-16 PAHs guidelines using Gas Chromatography (Agilent-6890N, USA). The drug's exposure-associated public health concerns was determined using suitable mathematical paradigms. PAHs present were acenaphthene (2.74 × 10 ), pyrene (2.7598 × 10 ), and chrysene (5.1277 × 10 ) ppm. Dietary intake of chrysene, acenaphthene and pyrene for adults, and children ranged from 2.466-4.615 × 10 and 1.215-2.308 × 10 ppm/mg/kg, respectively. B[α]Peq, EDB[α]Peq, and incremental lifetime cancer risk were determined to be 5.6777 × 10 , 5.109912 × 10 and 5.3289 × 10 , respectively. Our results suggest a high risk of non-carcinogenic adverse health effects, especially on chronic exposure among adolescents and adults, necessitating caution and/or avoidance of its chronic use. Therefore, policy formulation and implementation as regards the safety of plant-based remedies and allied products before their distribution among end-users must be ensured.
ISSN:0960-3123
1369-1619
DOI:10.1080/09603123.2024.2350591